drugset / Trial / NCT04086212

Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine

NCT04086212

Phase 2 Withdrawn Iperboreal Pharma Srl
RandomizedCrossoverOpen-labelTreatment

Summary

Randomized, cross-over, controlled, open label study. The aim of this study is to demonstrate that glucose may completely be replaced by a combination of xylitol and carnitine in the bimodal PD solution for long dwell exchange.

Timeline

Start
2019-10-02
Primary completion
2022-12
Completion
2023-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Icodextrin Other / unclassified 7.5 % Other
Subject L-carnitine Other / unclassified Other
Subject Xylitol Small molecule Other